Editorial: Emerging Markets' Health and Pharmaceutical Sectors at the Dawn of a Potential Global Financial Crisis of early 2020s.
作者信息
Jakovljevic Mihajlo, Lamnisos Demetris, Timofeyev Yuriy, Khan Habib Nawaz, Ranabhat Chhabi Lal, Godman Brian
机构信息
Institute of Advanced Manufacturing Technologies, Petersburg Polytechnic University, St.Petersburg, Russia.
Institute of Comparative Economic Studies, Hosei University, Tokyo, Japan.
出版信息
Front Pharmacol. 2022 Apr 25;13:907612. doi: 10.3389/fphar.2022.907612. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Emerging Markets' Health and Pharmaceutical Sectors at the Dawn of a Potential Global Financial Crisis of early 2020s.社论：21世纪20年代初潜在全球金融危机前夕新兴市场的卫生与制药行业
Front Pharmacol. 2022 Apr 25;13:907612. doi: 10.3389/fphar.2022.907612. eCollection 2022.
2
Real GDP growth rates and healthcare spending - comparison between the G7 and the EM7 countries.实际 GDP 增长率与医疗保健支出——G7 国家和 EM7 国家的比较。
Global Health. 2020 Jul 16;16(1):64. doi: 10.1186/s12992-020-00590-3.
3
Corporate Social Responsibility Amid Social Distancing During the COVID-19 Crisis: BRICS vs. OECD Countries.新冠疫情危机期间保持社交距离情况下的企业社会责任：金砖国家与经合组织国家对比
Res Int Bus Finance. 2021 Jan;55:101315. doi: 10.1016/j.ribaf.2020.101315. Epub 2020 Aug 18.
4
The Influence of Emerging Markets on the Pharmaceutical Industry.新兴市场对制药行业的影响。
Curr Ther Res Clin Exp. 2017 Apr 18;86:19-22. doi: 10.1016/j.curtheres.2017.04.005. eCollection 2017.
5
Future health spending forecast in leading emerging BRICS markets in 2030: health policy implications.2030 年金砖五国主要新兴市场的未来卫生支出预测：对卫生政策的影响。
Health Res Policy Syst. 2022 Feb 19;20(1):23. doi: 10.1186/s12961-022-00822-5.
6
Post COVID-19 exit strategies and emerging markets economic challenges.新冠疫情后的退出策略与新兴市场的经济挑战。
Rev Int Econ. 2022 Mar 17. doi: 10.1111/roie.12608.
7
Cross Country Determinants of Investors' Sentiments Prediction in Emerging Markets Using ANN.使用人工神经网络预测新兴市场投资者情绪的跨国决定因素
Front Artif Intell. 2022 Jun 15;5:912403. doi: 10.3389/frai.2022.912403. eCollection 2022.
8
Financial Times Global Pharmaceutical & Biotechnology Conference 2009.2009年英国《金融时报》全球制药与生物技术大会
IDrugs. 2010 Jan;13(1):26-9.
9
Public-Private Partnership as a Path to Affordable Healthcare in Emerging Markets.公私伙伴关系是新兴市场实现可负担医疗保健的途径。
Forum Health Econ Policy. 2015 Jan 1;18(1):65-74. doi: 10.1515/fhep-2014-0023.
10
Is this time different? How the impact of the COVID-19 crisis on labour markets contrasts with that of the global financial crisis of 2008-09.这次情况不同吗？2019年冠状病毒病危机对劳动力市场的影响与2008 - 2009年全球金融危机的影响有何不同。
Int Labour Rev. 2022 Mar;161(1):125-148. doi: 10.1111/ilr.12230. Epub 2022 Feb 22.
引用本文的文献
1
The priority areas and possible pathways for health cooperation in BRICS countries.金砖国家卫生合作的优先领域和可能途径。
Glob Health Res Policy. 2023 Aug 28;8(1):36. doi: 10.1186/s41256-023-00318-x.
2
How to balance valuable innovation with affordable access to medicines in Belgium?如何在比利时平衡有价值的创新与民众负担得起的药品可及性？
Front Pharmacol. 2022 Sep 16;13:960701. doi: 10.3389/fphar.2022.960701. eCollection 2022.
本文引用的文献
1
The Global South political economy of health financing and spending landscape - history and presence.全球南方卫生筹资和支出格局的政治经济学——历史与现状。
J Med Econ. 2021 Nov;24(sup1):25-33. doi: 10.1080/13696998.2021.2007691.
2
COVID-19 Pandemic: An Opportunity for Universal Health Coverage.新冠疫情：实现全民健康覆盖的契机。
Front Public Health. 2021 Jul 29;9:673542. doi: 10.3389/fpubh.2021.673542. eCollection 2021.
3
Corona-Triggered Global Macroeconomic Crisis of the Early 2020s.21世纪20年代初新冠疫情引发的全球宏观经济危机。
Int J Environ Res Public Health. 2020 Dec 15;17(24):9404. doi: 10.3390/ijerph17249404.
4
Predictors of (in)efficiencies of Healthcare Expenditure Among the Leading Asian Economies - Comparison of OECD and Non-OECD Nations.亚洲主要经济体医疗保健支出（无）效率的预测因素——经合组织国家与非经合组织国家的比较
Risk Manag Healthc Policy. 2020 Oct 21;13:2261-2280. doi: 10.2147/RMHP.S266386. eCollection 2020.
5
Real GDP growth rates and healthcare spending - comparison between the G7 and the EM7 countries.实际 GDP 增长率与医疗保健支出——G7 国家和 EM7 国家的比较。
Global Health. 2020 Jul 16;16(1):64. doi: 10.1186/s12992-020-00590-3.
6
Navigating COVID-19 in the developing world.发展中国家应对新冠疫情
Clin Rheumatol. 2020 Jul;39(7):2039-2042. doi: 10.1007/s10067-020-05159-4. Epub 2020 May 27.
7
Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries.双相情感障碍 II 型的药物治疗干预：针对多种症状的治疗方法及特殊关注中低收入国家的策略。
Expert Opin Pharmacother. 2019 Dec;20(18):2237-2255. doi: 10.1080/14656566.2019.1684473.
8
Analysis of the Financing of Russian Health Care over the Past 100 Years.过去100年俄罗斯医疗保健融资分析
Int J Environ Res Public Health. 2019 May 24;16(10):1848. doi: 10.3390/ijerph16101848.
9
Comparative financing analysis and political economy of noncommunicable diseases.非传染性疾病的比较融资分析与政治经济学。
J Med Econ. 2019 Aug;22(8):722-727. doi: 10.1080/13696998.2019.1600523. Epub 2019 Apr 8.
10
Evaluation of research on interventions aligned to WHO 'Best Buys' for NCDs in low-income and lower-middle-income countries: a systematic review from 1990 to 2015.低收入和中低收入国家与世界卫生组织非传染性疾病“最佳采购”措施相关的研究评估：1990年至2015年的系统综述
BMJ Glob Health. 2018 Feb 19;3(1):e000535. doi: 10.1136/bmjgh-2017-000535. eCollection 2018.
Zotero 插件